Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Paratek Pharmaceuticals, Inc. has filed 1,336 SEC EDGAR filings since 23 Jul 2002

SEC filing history

Showing 826-850 of 958 matching filings.

Per page
25
Current page
34
8-K File 000-51967

FORM 8-K

Filing date
01 Dec 2011
Reporting date
30 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SOLOWAY 11.23.11

Filing date
28 Nov 2011
Reporting date
23 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

KENNEDY 11/23/2011

Filing date
28 Nov 2011
Reporting date
23 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
25 Nov 2011
Reporting date
23 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
10 Nov 2011
Reporting date
10 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-81821

SC 13D/A

Filing date
10 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-51967

FORM 8-K AMENDMENT

Filing date
04 Nov 2011
Reporting date
15 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
18 Oct 2011
Reporting date
12 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
05 Oct 2011
Reporting date
04 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

WORTZMAN

Filing date
05 Oct 2011
Reporting date
04 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
28 Sep 2011
Reporting date
27 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-81821

SCHEDULE 13D

Filing date
28 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
23 Sep 2011
Reporting date
21 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
23 Sep 2011
Reporting date
21 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

INTERWEST/ EHRLICH PURCHASE

Filing date
22 Sep 2011
Reporting date
20 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

MAIN DOCUMENT DESCRIPTION

Filing date
22 Sep 2011
Reporting date
20 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

MAIN DOCUMENT DESCRIPTION

Filing date
22 Sep 2011
Reporting date
20 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

CONNIE PURCHASE 9/19/11

Filing date
20 Sep 2011
Reporting date
19 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
19 Sep 2011
Reporting date
19 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
15 Sep 2011
Reporting date
13 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SEPT 2011 PURCHASE

Filing date
13 Sep 2011
Reporting date
13 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
26 Aug 2011
Reporting date
24 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

2011 SPECIAL INCENTIVE GRANT

Filing date
25 Aug 2011
Reporting date
24 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

2011 SPECIAL INCENTIVE OPTION

Filing date
25 Aug 2011
Reporting date
24 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .